SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-23-071204
Filing Date
2023-06-14
Accepted
2023-06-14 16:16:17
Documents
1
Period of Report
2023-06-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318742-1_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2318742-1_4aseq1.xml 4/A 4181
  Complete submission text file 0001104659-23-071204.txt   5583
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Issuer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCODE THERAPEUTICS 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address
Dudley Robert Michael (Reporting) CIK: 0001854161 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40363 | Film No.: 231014316